ClinicalTrials.gov
ClinicalTrials.gov Menu

Clinical Importance of Carrier Status of Recessive Gene Mutations in Myopathy (CICS) (CICS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02897921
Recruitment Status : Not yet recruiting
First Posted : September 13, 2016
Last Update Posted : September 14, 2016
Sponsor:
Information provided by (Responsible Party):
Tove Freja Maria Fornander, Rigshospitalet, Denmark